For medtech device companies, biotech, health SaaS and AI health companies, and 503A and 503B compounding pharmacies. Pick your type, put in a few numbers, and see how many months of cash you have and what's tying it up.
Run my free cash checkFree. Only you see your numbers. From Tyler Clark, fractional CFO.
Sample result, made-up numbers
Runway: 11 months
An example result, made for this page. Yours uses your own numbers.
Four kinds of healthcare companies, each with its own money problems.
Pick what kind of company you run. The questions and the result change to fit. Rough numbers from your bank balance and last month's spend are fine.
The math runs in your browser. Nothing you type here is sent or stored.
Your next 12 months, from your numbers
A simple forecast from the numbers you typed: flat monthly spend and revenue, with milestone costs spread evenly. Your real picture needs your full books.
You leave knowing:
Want a link back to the check? Only your email address comes to Tyler, and he emails you a link back to the check. Your numbers never leave your browser.

Tyler Clark, fractional CFO for medtech device companies, biotech, health SaaS and AI health companies, and 503A and 503B compounding pharmacies. Finance degree from Texas A&M. He builds the model your board and investors trust, ties your budget to your milestones or product lines, and shows you where your cash is going.
Clark Advisory is new, so there are no client results to show yet. Here's what the diagnostic hands you instead:
| Months of runway today | 11 |
| Gap to next milestone | $180,000 |
| Month to start the raise | Month 3 |
| First move | Rebuild the budget around the milestone, then line up the raise |
Two weeks, built from your real books. For medtech and biotech: a runway model, a budget tied to your regulatory or clinical milestones, and a raise-readiness review of your numbers and data room, including grants. For health SaaS: burn, ARR, CAC payback and a Series-ready model. For compounding pharmacies: margin by product line, reimbursement and payer mix, and how long your cash is tied up. You get the moves that matter most, in order.
The first 3 companies, of any of the four types, get it at $1,500 instead of $2,500, until December 31, 2026. In exchange, you give a written case study and a review, if you're satisfied. After 3 spots, the regular $2,500 applies.
Live in 30 days, or your next month is free.
Book the 15-minute callThe call is where you ask about a founding spot.
Only you see your numbers. The check runs in your browser, and your numbers are never stored or sent to Tyler. If you ask for the email, only your email address comes to Tyler, and he emails you a link back to the check. Your numbers never leave your browser. If you book the call, you choose what to share on it. Read the privacy page.
Yes. Your bank balance, last month's spend and a few rough figures for your type are enough to see the shape of things.
Hiring plans, FDA or trial delays, reimbursement changes, grant timing, seasonality and anything not in the numbers you typed. That's what the diagnostic works through with your full books.
Yes. Pick compounding pharmacy in the check. You get margin by product line, your cash conversion cycle and how much of your sales depend on PBMs or insurance.
Tyler gets your numbers, model and data room ready to raise and works alongside your team and advisors. He is a fractional CFO, not a broker-dealer, and does not sell securities.
You and Tyler look at your result together. You leave knowing what it means, what to do first, and whether the diagnostic fits.